Developing Subcutaneous Formulations for Irisin as a Potential Therapeutic. [PDF]
Pharm ResHu G, Luan X, Hageman MJ, Lou H.
europepmc +1 more source
Irisin Increases Sirtuin 1 to Improve Glucocorticoid-Induced Sarcopenia and Mitochondrial Dysfunction. [PDF]
CellsShi H +12 more
europepmc +1 more source
Irisin deficiency exacerbates cardiac dysfunction and enhances hemorrhage injury in hemorrhage/resuscitation. [PDF]
Am J Physiol Regul Integr Comp PhysiolKulthinee S +8 more
europepmc +1 more source
Irisin Research Landscape (2012-2024): A Bibliometric and Visual Analysis of Evolving Hotspots and Future Trends. [PDF]
BiologicsGao L +5 more
europepmc +1 more source
Inflammation-Insulin Resistance Crosstalk and the Central Role of Myokines. [PDF]
Int J Mol SciDobre MZ +4 more
europepmc +1 more source
Corrigendum to "Irisin in Type 2 Diabetes and Obesity: A Biomarker of Metabolic and Lipid Dysregulation". [PDF]
Clin Med Insights Endocrinol Diabeteseuropepmc +1 more source
Systemic Inflammatory and Oxidative-Metabolic Alterations in Rosacea: A Cross-Sectional Case-Control Study. [PDF]
Diagnostics (Basel)Esen M +3 more
europepmc +1 more source
The Muscle-Brain Axis in Aging: Mechanistic and Clinical Perspectives on Resistance Training and Cognitive Function. [PDF]
Biology (Basel)Yu S +6 more
europepmc +1 more source
Exercise and Carnosine Modulate Microbiota-Derived Metabolites, Myokines, and Cardiometabolic Profiles in Rats: A Randomized Controlled Trial. [PDF]
BiomedicinesBozbay K +7 more
europepmc +1 more source